Literature DB >> 3342902

Immunohistologic characterization and quantitation of leukocyte subpopulations in human semen.

H Wolff1, D J Anderson.   

Abstract

Various major leukocyte subpopulations (granulocytes, monocytes/macrophages, B lymphocytes, helper and suppressor/cytotoxic T lymphocytes) were detectable in human semen by applying monoclonal antibodies (MAbs) specific for pan-leukocyte and leukocyte subpopulation markers. MAb-labeled cells in smears of washed human semen were visualized by a standard streptavidin-biotin immunoperoxidase method. This approach was validated by testing the MAb panel against sections of human testis and epididymis to rule out cross-reactivity with immature germ cells or other reproductive tract cells, and against peripheral blood leukocytes that had been incubated in human semen to ascertain leukocyte marker stability in seminal plasma. When the immunoperoxidase technique was applied to semen smears from 17 proven fertile men and 51 randomly selected infertility patients, the authors found highly varying total leukocyte numbers, ranging from 8970 to 20,520,000 per ejaculate among fertile men (median, 170,000), and from 43,120 to 104,580,000 among infertility patients (median, 1,035,000). Higher means and medians of granulocytes, monocytes/macrophages, and lymphocyte subsets were seen in the infertility group. These results warrant further investigation on the diagnostic utility of semen leukocyte profiles and the possible role of seminal leukocytes in male infertility.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342902

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  32 in total

1.  Immature germ cells in semen and their correlations with other semen parameters.

Authors:  T Caşkurlu; A I Tasci; M Samasti; Z Bayraktar; M Cek; G Sevin
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

Review 2.  Semen analysis in laboratory practice: an overview of routine tests.

Authors:  Fernando Tadeu Andrade-Rocha
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

Review 3.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

4.  Phosphorothioate 2' deoxyribose oligomers as microbicides that inhibit human immunodeficiency virus type 1 (HIV-1) infection and block Toll-like receptor 7 (TLR7) and TLR9 triggering by HIV-1.

Authors:  Joseph A Fraietta; Yvonne M Mueller; Duc H Do; Veronica M Holmes; Mary K Howett; Mark G Lewis; Alina C Boesteanu; Sefik S Alkan; Peter D Katsikis
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

5.  Cell-mediated infection of cervix derived epithelial cells with primary isolates of human immunodeficiency virus.

Authors:  X Tan; D M Phillips
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Detection of feline immunodeficiency virus in semen from seropositive domestic cats (Felis catus).

Authors:  H L Jordan; J Howard; W A Tompkins; S Kennedy-Stoskopf
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Glass wool filtration reduces reactive oxygen species by elimination of leukocytes in oligozoospermic patients with leukocytospermia.

Authors:  R Sánchez; M Concha; T Ichikawa; R Henkel; W B Schill
Journal:  J Assist Reprod Genet       Date:  1996-07       Impact factor: 3.412

9.  Nonsurgical treatment of male infertility: specific and empiric therapy.

Authors:  Marcello Cocuzza; Ashok Agarwal
Journal:  Biologics       Date:  2007-09

10.  Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.

Authors:  Kristina E Howard; Stacie K Reckling; Erin A Egan; Gregg A Dean
Journal:  Retrovirology       Date:  2010-01-19       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.